Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 AUD | -6.25% | +294.74% | -43.18% |
04-23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
04-23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
3D-printed Biomimetic and Bioresorbable Implants
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +31.02% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore
51.4
%
| 2 | 100.0 % | 1 | 51.4 % | -32.61% |
South Korea
48.6
%
| - | - | 1 | 48.6 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Lim
CEO | Chief Executive Officer | - | 30/11/14 |
Ning Voon Shu
AUD | Comptroller/Controller/Auditor | - | - |
Kellie Davis
SEC | Corporate Secretary | - | 25/01/23 |
Khoon Seng Goh
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Wei Leong
CHM | Chairman | 49 | 31/07/21 |
Michael Keenan
BRD | Director/Board Member | - | 17/07/23 |
Swee Hin Teoh
BRD | Director/Board Member | - | 23/06/19 |
Daniel Ow
BRD | Director/Board Member | - | 06/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,615,579 | 109,527,462 ( 96.40 %) | 0 | 96.40 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-43.18% | 2.69M | |
-2.75% | 187B | |
-2.06% | 106B | |
-4.53% | 66.9B | |
+0.60% | 49.45B | |
+16.47% | 48B | |
+4.06% | 40.84B | |
+3.20% | 26.48B | |
+0.68% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- OSX Stock
- Company Osteopore Limited